BML Inc
BML, Inc. provides contract clinical testing and related services in Japan. The company offers a range of laboratory testing, such as biochemical and hematologic examination; laboratory test, including tumor markers, infectious diseases, hormones, cellular immunity, genetics, bacteriological tests, and other test; specialized testing in oncology, infectious diseases, diabetes, hypertension, aller… Read more
BML Inc (BMZ) - Total Assets
Latest total assets as of September 2025: €173.81 Billion EUR
Based on the latest financial reports, BML Inc (BMZ) holds total assets worth €173.81 Billion EUR as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
BML Inc - Total Assets Trend (2016–2025)
This chart illustrates how BML Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
BML Inc - Asset Composition Analysis
Current Asset Composition (March 2025)
BML Inc's total assets of €173.81 Billion consist of 57.6% current assets and 42.4% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 38.1% |
| Accounts Receivable | €26.82 Billion | 15.1% |
| Inventory | €4.68 Billion | 2.6% |
| Property, Plant & Equipment | €0.00 | 0.0% |
| Intangible Assets | €4.99 Billion | 2.8% |
| Goodwill | €0.00 | 0.0% |
Asset Composition Trend (2016–2025)
This chart illustrates how BML Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: BML Inc's current assets represent 57.6% of total assets in 2025, a decrease from 62.2% in 2016.
- Cash Position: Cash and equivalents constituted 38.1% of total assets in 2025, up from 37.3% in 2016.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 2.0% of total assets, a decrease from 3.0% in 2016.
- Asset Diversification: The largest asset category is accounts receivable at 15.1% of total assets.
BML Inc Competitors by Total Assets
Key competitors of BML Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
ADCNF
OTCGREY:ADCNF
|
USA | $4.51 Billion |
|
Berry Genomics Co Ltd
SHE:000710
|
China | CN¥2.34 Billion |
|
Malaysian Genomics Resource
KLSE:0155
|
Malaysia | RM20.70 Million |
|
NSN Co. Ltd
KQ:031860
|
Korea | ₩60.96 Billion |
|
JOONGANG DNM Co.Ltd
KQ:051980
|
Korea | ₩121.79 Billion |
|
GeneMatrix Inc
KQ:109820
|
Korea | ₩28.03 Billion |
|
Genoray Co. Ltd
KQ:122310
|
Korea | ₩125.67 Billion |
|
Green Cross Lab Cell Corporation
KQ:144510
|
Korea | ₩565.79 Billion |
BML Inc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - BML Inc generates 0.81x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Moderate ROA - For every $100 in assets, BML Inc generates $ 3.53 in net profit.
BML Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.61 | 2.89 | 2.69 |
| Quick Ratio | 2.49 | 2.77 | 2.57 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €61.02 Billion | € 66.37 Billion | € 50.45 Billion |
BML Inc - Advanced Valuation Insights
This section examines the relationship between BML Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.21 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 3.8% |
| Total Assets | €177.51 Billion |
| Market Capitalization | $462.01 Million USD |
Valuation Analysis
Below Book Valuation: The market values BML Inc's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: BML Inc's assets grew by 3.8% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for BML Inc (2016–2025)
The table below shows the annual total assets of BML Inc from 2016 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-03-31 | €177.51 Billion | +3.81% |
| 2024-03-31 | €170.99 Billion | +1.21% |
| 2023-03-31 | €168.94 Billion | -5.72% |
| 2022-03-31 | €179.20 Billion | +28.76% |
| 2021-03-31 | €139.17 Billion | +19.70% |
| 2020-03-31 | €116.27 Billion | +0.26% |
| 2019-03-31 | €115.97 Billion | +5.96% |
| 2018-03-31 | €109.45 Billion | +4.99% |
| 2017-03-31 | €104.24 Billion | +4.88% |
| 2016-03-31 | €99.39 Billion | -- |